SCPH: scPharmaceuticals Inc. Stock

by  •  • Comments Off on SCPH: scPharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 191.63
Enterprise Value ($M) 185.14
Book Value ($M) -5.13
Book Value / Share -0.10
Price / Book -37.38
NCAV ($M) -6.74
NCAV / Share -0.13
Price / NCAV -28.45

Profitability (mra)
Return on Invested Capital (ROIC) -1.92
Return on Assets (ROA) -1.16
Return on Equity (ROE) -3.70

Liquidity (mrq)
Quick Ratio 4.61
Current Ratio 5.48

Balance Sheet (mrq) ($M)
Current Assets 89.35
Assets 90.96
Liabilities 96.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.33
Operating Income -64.78
Net Income -85.15
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -70.54
Cash from Investing 29.30
Cash from Financing 70.08

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-28 13G/A King Luther Capital Management Corp 6.50 9.02
01-31 13G/A Hirschman Orin 8.40 35.21
11-14 13G/A Lytton Laurence W 5.90 61.35
11-14 13G/A Lundbeckfond Invest A/S 5.70 -10.05
08-15 13D/A Orbimed Advisors Llc 12.10 8.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q Inventory Research and Development Costs Selling, General, and Administrative Costs
2025-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-12-31 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANS
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 48,995 243,407 20.13
2025-05-29 48,908 279,070 17.53
2025-05-28 34,548 220,861 15.64
2025-05-27 48,542 269,725 18.00

(click for more detail)

Similar Companies
RVMD – Revolution Medicines, Inc. RXRX – Recursion Pharmaceuticals, Inc.
SANA – Sana Biotechnology, Inc. SDGR – Schrödinger, Inc.
SLDB – Solid Biosciences Inc.


Financial data and stock pages provided by
Fintel.io